Nautic Partners, The Vistria Group and General Atlantic have agreed to buy rare pharmacy care specialist PANTHERx Rare from Centene Corporation. The post Rare disease pharmacy specialist PANTHERx bought by private equity consortium first appeared on
Teachers' Venture Growth (TVG), the venture arm of the Ontario Teachers’ Pension Plan Board, has led a EUR 183m Series E investment in French health tech company Alan.
RoundTable Healthcare Partners has hit an $800m final close for its sixth private equity fund, bringing its total raised since inception to $4.25bn. The post Roundtable Healthcare Partners passes $4bn of capital raised thanks to
Private equity firm Astorg has acquired German CDMO CordenPharma from International Chemical Investors Group (ICIG).
French private equity group Astorg has agreed a buyout of drug contract development and manufacturing business CordenPharma in a deal reportedly worth more than €2.5bn. The post Astorg agrees CordenPharma carve-out in deal said to exceed
Gilde Healthcare has mandated Lincoln International to sell DACH radiology asset RAD-X, according to four sources familiar with the situation.
Healthcare and tech-focused private equity major Welsh, Carson, Anderson & Stowe is more than 80% of the way to its $5bn target for its latest flagship fundraise. The firm has registered just over $4bn of commitments
US and Asia-based investor MassMutual Ventures has expanded to Europe through the launch of a $300m fund targeting early and growth-stage companies in digital health, financial technology, enterprise SaaS and cybersecurity. The post MassMutual Ventures makes
HealthTech-focused Flare Capital Partners has reached the $350m target for its third flagship fundraise. The post HealthTech investor Flare Capital strikes $350m goal in third flagship fundraise first appeared on AltAssets Private Equity News.
Healthcare-focused buyout house Lead Capital Partners has hired former Gen Cap America senior exec Lamar Stanley as a director. The post Healthcare-focused Lead Capital Partners brings in ex-Gen Cap America exec Stanley as director first
Enhanced Healthcare Partners has promoted Brandon Einstein to partner after seven years with the firm. The post Enhanced Healthcare Partners promotes Einstein to partner first appeared on AltAssets Private Equity News.
The Texas County and District Retirement System has agreed more than $100m of new private equity and venture capital commitments. TCDRS said it would commit $95m to Water Street Healthcare Partners V, a $1.4bn private
Mid-market private equity firm Inflexion has acquired British CDMO Upperton Pharma Solutions.
European buyout house Inflexion Private Equity has made what it calls a "substantial" investment into UK specialist contract development and manufacturing organisation Upperton Pharma Solutions. The post Inflexion buys into pharma industry particle engineering specialist Upperton
Belgian investor Groupe Bruxelles Lambert (GBL) has acquired DACH ophthalmology clinics company Sanoptis from Telemos Capital.
Private equity firm KKR has made a takeover bid for Ramsay Health Care, an Australia-listed hospital group which has nearly EUR 760m of EBITDA in European operations.
Global buyout giant KKR has led a consortium to file a record $14.8bn bid for Australian hospital operator Ramsay Health Care, making it potentially the biggest private equity-backed buyout deal for an Australian company. The
Healthcare-focused buyout house ArchiMed has agreed to take medical device maker Natus Medical private for $1.2bn. The post ArchiMed to take medical device maker Natus Medical private for $1.2bn first appeared on AltAssets Private Equity News.
Private equity firm Carlyle has acquired UK-based life sciences investment firm Abingworth as it jumps on a trend of asset managers driving towards specialisation, particularly in healthcare.
Healthcare-focused private equity house Havencrest Capital Management has beaten its target for its second fund thanks to strong performance from its debut investment vehicle. The post Strong Fund I performance helps healthcare-focused Havencrest beat $300m
